Physician profile
Nerissa S Torio
NPI 1558858928
$1,012.35
in general payments reported to CMS, 2019-2025
19 companies · $657 in 2025
The $657 reported for 2025 was more than what 78% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $58.72 · 2023: $43.60 · 2024: $253 · 2025: $657.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $954.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $953.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $172.02 | 2025 | Freestyle Libre |
| Novo Nordisk INC | $140.10 | 2024-2025 | Rybelsus, Ozempic |
| Astrazeneca Pharmaceuticals LP | $106.77 | 2024-2025 | Airsupra, Farxiga |
| Lilly USA, LLC | $92.56 | 2022-2025 | Zepbound, Mounjaro |
| Glaxosmithkline, LLC. | $73.96 | 2024-2025 | Arexvy, Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $53.18 | 2025 | Jardiance |
| Pfizer INC. | $51.58 | 2025 | |
| Dexcom, INC. | $50.63 | 2025 | Dexcom G6 Transmitter |
| Corcept Therapeutics | $45.80 | 2025 | Korlym |
| Amgen INC. | $30.82 | 2022-2024 | Repatha |
| Phathom Pharmaceuticals, INC. | $29.22 | 2024 | Voquezna |
| Sanofi-Aventis U.S. LLC | $23.92 | 2023 | |
| Exact Sciences Corporation | $23.35 | 2024 | Cologuard Collection Kit |
| Mannkind Corporation | $21.91 | 2025 | |
| Daiichi Sankyo INC. | $20.36 | 2025 | Injectafer |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $19.68 | 2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.07 | 2025 | Xifaxan |
| Scilex Pharmaceuticals INC. | $18.86 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.56 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nerissa Torio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.